| A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer DJ Cheon, Y Tong, MS Sim, J Dering, D Berel, X Cui, J Lester, JA Beach, ... Clinical cancer research 20 (3), 711-723, 2014 | 420 | 2014 |
| Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism PJP Aspuria, SY Lunt, L Väremo, L Vergnes, M Gozo, JA Beach, ... Cancer & metabolism 2, 1-15, 2014 | 172 | 2014 |
| Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer EL Christie, S Pattnaik, J Beach, A Copeland, N Rashoo, S Fereday, ... Nature communications 10 (1), 1295, 2019 | 158 | 2019 |
| Mechanisms of drug resistance in high-grade serous ovarian cancer AE Freimund, JA Beach, EL Christie, DDL Bowtell Hematology/Oncology Clinics 32 (6), 983-996, 2018 | 120 | 2018 |
| Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system WR Wiedemeyer, JA Beach, BY Karlan Frontiers in oncology 4, 34, 2014 | 77 | 2014 |
| Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer JA Beach, PJP Aspuria, DJ Cheon, K Lawrenson, H Agadjanian, ... Oncotarget 7 (4), 4167, 2016 | 61 | 2016 |
| Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation Z Liu, JA Beach, H Agadjanian, D Jia, PJ Aspuria, BY Karlan, S Orsulic Gynecologic oncology 139 (3), 394-400, 2015 | 58 | 2015 |
| Going to extremes: determinants of extraordinary response and survival in patients with cancer FAM Saner, A Herschtal, BH Nelson, A deFazio, EL Goode, SJ Ramus, ... Nature Reviews Cancer 19 (6), 339-348, 2019 | 40 | 2019 |
| ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma DJ Cheon, AJ Li, JA Beach, AE Walts, H Tran, J Lester, BY Karlan, ... Carcinogenesis 36 (7), 739-747, 2015 | 29 | 2015 |
| Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas DJ Cheon, AE Walts, JA Beach, J Lester, JS Bomalaski, CS Walsh, ... The Journal of Pathology: Clinical Research 1 (1), 41-53, 2015 | 26 | 2015 |
| E4BP4 facilitates glucocorticoid-evoked apoptosis of human leukemic CEM cells via upregulation of Bim JA Beach, LJ Nary, Y Hirakawa, E Holland, R Hovanessian, RD Medh Journal of Molecular Signaling 6 (1), 1-13, 2011 | 23 | 2011 |
| Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism. Cancer Metab. 2014; 2: 21 PP Aspuria, SY Lunt, L Varemo, L Vergnes, M Gozo, JA Beach, ... Epub 2015/02/12. doi: 10.1186/2049-3002-2-21. PubMed PMID: 25671108, 2014 | 14 | 2014 |
| HOXB13 controls cell state through super-enhancers PJ Aspuria, DJ Cheon, MC Gozo, JA Beach, MS Recouvreux, AE Walts, ... Experimental Cell Research 393 (1), 112039, 2020 | 10 | 2020 |
| Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models E Morrish, A Copeland, DM Moujalled, JA Powell, N Silke, A Lin, ... Blood Advances 4 (20), 5062-5077, 2020 | 8 | 2020 |
| Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro-and anti-apoptotic genes in CEM human lymphoblastic leukemia cells JA Beach, LJ Nary, R Hovanessian, RD Medh Biochemical and biophysical research communications 451 (3), 382-388, 2014 | 7 | 2014 |
| Commentary on “Epithelial–to–Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer” JA Beach, DDL Bowtell Cancer Research 76 (24), 7075-7077, 2016 | 4 | 2016 |
| Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer KI Pishas, KJ Cowley, A Pandey, T Hoang, JA Beach, J Luu, R Vary, ... Cancers 13 (22), 5644, 2021 | 2 | 2021 |
| The MOCOG study: Learning from extraordinary responders to improve treatment outcomes for women with ovarian cancer A de Fazio, DW Garsed, A Pandey, S Fereday, K Alsop, MCA Wouters, ... Pathology 52, S30-S31, 2020 | 1 | 2020 |
| The genomic landscape of high-grade serous ovarian cancer in long-term survivors DW Garsed, A Pandey, S Fereday, K Alsop, MC Wouters, F Saner, ... Cancer Research 79 (13_Supplement), 2722-2722, 2019 | 1 | 2019 |
| Acquired chemotherapy resistance in high-grade serous ovarian cancer patients. EL Christie, J Beach, D Etemadmoghadam, D Garsed, AM Patch, ... Clinical Cancer Research 24 (15), 20-20, 2018 | 1 | 2018 |
